HCV Coinfection

20 registered clinical trials studyying HCV Coinfection.

Status	Trial	Sponsor	Phase
Unknown	Effect of Sofosbuvir-daclatasuvir on Angiogenesis NCT03646396	Sherief Abd-Elsalam	N/A
Completed	Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease NCT03499639	Assiut University	Phase 4
Unknown	Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy NCT03549312	Saskatchewan Health Authority - Regina Area	Phase 4
Completed	Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure NCT03549832	Assiut University	N/A
Completed	Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID) NCT03214679	City University of New York, School of Public Health	N/A
Completed	Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic NCT03050905	HaEmek Medical Center, Israel	Phase 4
Completed	deLIVER: Direct Acting Antiviral Effects on the Liver NCT02938013	Johns Hopkins University	Phase 4
Completed	Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03) NCT03145753	Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal	N/A
Completed	Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents NCT03508115	Corporacion Parc Tauli	—
Completed	Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated NCT02505243	Radboud University Medical Center	—
Completed	Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection NCT01900015	Juan Macías	Phase 4
Completed	Integrating HIV and Hepatitis C Screening in an Urban Emergency Department NCT03252483	New York City Health and Hospitals Corporation	N/A
Completed	Folinic Acid: Supplementation and Therapy NCT02810275	Hospital de Clinicas de Porto Alegre	Phase 3
Completed	Testing and Linkage to Care for Injecting Drug Users in Kenya NCT01557998	Yale University	N/A
Unknown	Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection NCT01529073	Juan Macías	Phase 2
Completed	Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin NCT01335529	ANRS, Emerging Infectious Diseases	Phase 2
Completed	The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients NCT01335230	University of Cincinnati	—
Completed	HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir NCT01222611	Fundacion SEIMC-GESIDA	Phase 4
Terminated	Ultrasound Method to Measure Fibrosis of the Liver in Children NCT02086708	Massachusetts General Hospital	N/A
Completed	Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients NCT02693847	Hospital Universitario de Valme	—